AorTech International Plc’s stock jumps more than 28.0% over New Licence Agreement

  • Nov 27, 2019 GMT
  • Team Kalkine
  • Licensor of the world's leading long-term implantable biostable polymer and developer of medical devices enabled by Elast-Eon™- AorTech International Plc (LON: AOR), on November 27 announced that it has entered into an IP licence agreement with Medibrane Limited permitting the use of Elast-Eon™ for encapsulation of medical devices.
  • Its shares zoomed at the London bourse and were up by 22.50 points or 28.12% to GBX 102.50 (at the time of writing at 02:11 PM GMT, before the market close) and touched an intraday high of GBX 102.50 and a low of GBX 80.0, during the session respectively.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK